Table 3.
compd | α−1A Ki ± SEM (nM) | α−1B Ki ± SEM (nM) | α−1D Ki ± SEM (nM) | α−2A Ki ± SEM (nM) | α−2B Ki ± SEM (nM) | α−2C Ki ± SEM (nM) |
---|---|---|---|---|---|---|
WB 4101b | 0.16 | 0.038 | ND | ND | ND | ND |
prazosin | ND | ND | 0.17 ± 0.03 | ND | ND | ND |
yohimbineb | ND | ND | ND | 3.13 | 1.16 | 0.80 |
corynantheidine | ND | ND | 41.7 ± 4.7 | ND | ND | ND |
mitragynine | 1340 ± 100 | 4770 ± 120 | 5480 ± 540 | 4720 ± 120 | 9290 ± 30 | 2320 ± 140 |
ND: Not determined because there was less displacement of radioligand at 10,000 nM of test compound (Table 1).
These data points were conducted once; studies are still ongoing with other kratom alkaloids and the test controls will be repeated.